Optimizing Therapy for Patients with Acute and Chronic Graft-Versus-Host Disease (GvHD) - Episode 3

Optimal First-Line Treatment Approaches for Acute GvHD

July 14, 2023

Michael R. Bishop, MD, University of Chicago, Hannah Choe, MD, Doris M. Ponce, MD, Bart L. Scott, MD

Subject-matter experts delve into the diagnosis, risk assessment, and treatment selection process for acute GvHD, emphasizing differentiation of refractory disease.

Video Player is loading.

Current Time 0:00

Duration 4:55

Loaded: 0%

Stream Type LIVE

Remaining Time 4:55

EP. 1: Understanding Chronic and Acute Graft-Versus-Host Disease Presentation and Diagnosis

EP. 2: Improving Patient Outcomes: Prophylactic Options in Graft-Versus-Host Disease

Now Viewing

EP. 3: Optimal First-Line Treatment Approaches for Acute GvHD

EP. 4: Treatment Options in Steroid-Refractory Acute GvHD

EP. 5: Enhancing Patient Care in Acute GvHD: Supportive Measures

EP. 6: Advancements and Promising Directions in Acute GvHD

EP. 7: Establishing Treatment Objectives for Chronic GvHD: First-Line Strategies

EP. 8: A Comprehensive Look at Initial Treatment Options for Chronic GvHD

EP. 9: Data-Driven Treatment Selection for Patients with Chronic GvHD

EP. 10: Remote Patient Monitoring and Supportive Care Measures in Chronic GvHD

EP. 11: The Future of Chronic GvHD Treatment

EP. 12: Dr Rifkin on the Role of Belantamab Mafodotin in Relapsed/Refractory Multiple Myeloma